Drug reference
sodium tetradecyl sulfate
Sclerosing agent
Sclerosing agent
CDSCO approved
EXCRETION
—
not curated
INTERACTIONS
—
none in our sources
PREGNANCY
—
not curated
Mechanism
Causes inflammation, coagulation, and ultimately fibrosis when injected.
Indications
Injection into haemorrhoidsInjection into varicose vein mass
Dosing
- Adult
- 0.5–2 ml at each site (3% with benzyl alcohol 2%)
Related guidelines
Other Sclerosing agent drugs
Ask House about sodium tetradecyl sulfate
Continue into a citation-backed clinical answer with the drug context already attached.
Textbook-sourced·Sources: KD Tripathi 7e·Updated: 2026-05-10